Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ampcare is a medical technology company dedicated to improving the quality of life for patients suffering from dysphagia, or swallowing disorders. The company's flagship offering is the Effective Swallowing Protocol (ESP), an FDA-cleared therapeutic intervention. ESP integrates neuromuscular electrical stimulation (NMES) with a series of resistive swallowing exercises to rehabilitate the muscles responsible for airway protection. Unlike traditional stimulation methods, Ampcare utilizes a proprietary waveform and specialized E-Series electrodes to achieve more effective muscle recruitment. In addition to providing medical devices, the company offers extensive certification and training programs for speech-language pathologists. Ampcare's solutions are used across various clinical settings, including hospitals, skilled nursing facilities, and outpatient clinics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ampcare.